Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,418.25 +334.29 (+0.53%) CMC Crypto 200
1,317.57 +40.59 (+3.18%)
Protagonist Therapeutics, Inc. (PTGX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.53B |
| Enterprise value | 1.19B |
| Trailing P/E | N/A |
| Forward P/E | 14.49 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 24.68 |
| Price/book (mrq) | 4.54 |
| Enterprise value/revenue | 19.83 |
| Enterprise value/EBITDA | -13.17 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.05 |
| 52-week change 3 | 2.45% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 33.34 |
| 52-week low 3 | 13.72 |
| 50-day moving average 3 | 28.13 |
| 200-day moving average 3 | 21.90 |
Share statistics
| Avg vol (3-month) 3 | 576.48k |
| Avg vol (10-day) 3 | 483.13k |
| Shares outstanding 5 | 58.64M |
| Implied shares outstanding 6 | 58.64M |
| Float 8 | 40.77M |
| % held by insiders 1 | 1.69% |
| % held by institutions 1 | 102.65% |
| Shares short (15 Apr 2024) 4 | 3.52M |
| Short ratio (15 Apr 2024) 4 | 5.85 |
| Short % of float (15 Apr 2024) 4 | 6.10% |
| Short % of shares outstanding (15 Apr 2024) 4 | 6.01% |
| Shares short (prior month 15 Mar 2024) 4 | 3.42M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -131.59% |
| Operating margin (ttm) | 38.41% |
Management effectiveness
| Return on assets (ttm) | -19.32% |
| Return on equity (ttm) | -28.59% |
Income statement
| Revenue (ttm) | 60M |
| Revenue per share (ttm) | 1.06 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -92.67M |
| Net income avi to common (ttm) | -78.95M |
| Diluted EPS (ttm) | -1.39 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 341.62M |
| Total cash per share (mrq) | 5.86 |
| Total debt (mrq) | 1.14M |
| Total debt/equity (mrq) | 0.34% |
| Current ratio (mrq) | 16.71 |
| Book value per share (mrq) | 5.83 |
Cash flow statement
| Operating cash flow (ttm) | -70.24M |
| Levered free cash flow (ttm) | -43.31M |
© 2024 Yahoo. All rights reserved.